Additionally, SIRT1 is highly expressed in various cancers [35, 67] such as prostate cancer, and high levels of SIRT1 expression are associated with a poor prognosis in lung cancer, breast cancer, gastric carcinomas, and B-cell lymphoma [68–71]. Here, SIRT1 is linked to lung carcinoma.